Older stimulant appetite suppressants Drugs like phentermine and diethylpropion once filled this role, but are no longer marketed in Canada
Current drugs and potential future neuroprotective compounds for Parkinsons disease
Your prescriber will consider your current dose, side effects, medical history and treatment response
Bringing genetic and biomarker context to your provider allows for a more personalized discussion about dose titration, expected adaptation timelines, and symptom management strategies tailored to your metabolic profile
confirmed that miR-192 directly acts on the 3UTR of sterol regulatory element binding transcription factor 1 (SREBF1) and contributes to the dysregulation of lipid homeostasis in hepatocytes
While the data are promising, we do not yet know the long-term consequences of chronically manipulating one of the bodys most important metabolic signaling systems